18-72864831-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138966.5(NETO1):c.197G>A(p.Arg66Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138966.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NETO1 | NM_138966.5 | c.197G>A | p.Arg66Gln | missense_variant | 3/11 | ENST00000327305.11 | NP_620416.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NETO1 | ENST00000327305.11 | c.197G>A | p.Arg66Gln | missense_variant | 3/11 | 1 | NM_138966.5 | ENSP00000313088 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000957 AC: 24AN: 250662Hom.: 0 AF XY: 0.0000812 AC XY: 11AN XY: 135480
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461296Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726940
GnomAD4 genome AF: 0.000329 AC: 50AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | The c.197G>A (p.R66Q) alteration is located in exon 3 (coding exon 3) of the NETO1 gene. This alteration results from a G to A substitution at nucleotide position 197, causing the arginine (R) at amino acid position 66 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at